<!DOCTYPE html>

<html>
<head>
<meta charset="utf-8"/>
<meta content="width=device-width, initial-scale=1.0" name="viewport"/>
<link href="../../../webpages.css" rel="stylesheet"/>
</head>
<body>
<div class="banner">
<div class="banner-content">
<h1>DermpathNet</h1>
</div>
</div>
<nav>
<a href="../../../index.html" target="_blank">
<text type="button">Home</text>
</a>
<a href="../../../browser-page-317.html" target="_blank">
<text type="button">Browse</text>
</a>
<a href="../../../download-page.html" target="_blank">
<text type="button">Downloads</text>
</a>
<a href="../../../contact-us.html" target="_blank">
<text type="button">About</text>
</a>
</nav>
<footer class="site-footer">
<p>@2024 New York University Grossman School of Medicine, Weill Cornell Medicine</p>
<!--<p>Privacy Policy | Terms of Service | Cookie Policy</p>-->
</footer>
<title>FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential.-DermPath</title>
<div class="content-container"> <div class="figures-container"> <div class="image-side"> <img alt="FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential." class="clickable-image" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6e22/3641332/4a9451ee419c/cddis2013109f3.jpg"/> </div> <div class="text-side"> <h1>FK506 binding protein 51 positively regulates melanoma stemness and metastatic potential.</h1> <p>Malignant invasive melanocytes are double-stained with nuclear FKBP51(brown) and cytoplasmic/membranous nestin (red). (a) FKBP51/nestin staining of a primary melanoma: blue arrows: malignant melanocytes, negative for FKBP51 and nestin (thin arrows: radial, noninvasive growth phase; thick arrows: vertical, invasive growth phase); red arrows: malignant melanocytes double immunostained with FKBP51 and nestin, in vertical, invasive growth phase of melanoma (IHC, × 100). Malignant melanocytes negative for FKBP51 and nestin are detectable in both radial and vertical growth phases. FKBP51/nestin double-stained malignant melanocytes are observed in the vertical growth phase. Enlarged details of double-negative and double-positive melanocytes are shown on the right. (b) Neoplastic embolus in a dermal vessel of skin melanoma containing double-stained melanocytes (IHC: × 400); melanin pigment is visible outside of the vessel. (c) Vascular invasion of double-stained melanoma cells in brain metastasis (IHC, × 400). (d) Melanoma brain metastasis, FKBP51/nestin-positive cells form aggregates with a preferentially perivascular localization (IHC: × 50, × 100, × 400). (e) Brain metastasis, the cerebral tissue is completely substituted by double-stained malignant melanocytes (IHC: × 100, × 200). (f) The same case showed in (a), malignant melanocytes are immunostained with MART-1. Radial growth phase: thin blue arrows; vertical growth phase: thick blue arrows. (g) A serial section of the case showed in (e), malignant melanocytes are immunostained with MART-1</p> <p>PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/23559012/" target="_blank">23559012</a></p><p>Type: Premalignant/Malignant, Category: Melanocytic</p>
</div> </div></div></body></html>